273 related articles for article (PubMed ID: 9723697)
1. Activation of B cells by 1 microm particulate lysozyme or peptides: a Th-dependent pathway requiring CD40-CD40 ligand interaction.
Sedlik C; Rojas M; Leclerc C
Int Immunol; 1998 Aug; 10(8):1111-9. PubMed ID: 9723697
[TBL] [Abstract][Full Text] [Related]
2. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
3. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
4. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
[TBL] [Abstract][Full Text] [Related]
5. In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant.
Gengoux C; Leclerc C
Int Immunol; 1995 Jan; 7(1):45-53. PubMed ID: 7718515
[TBL] [Abstract][Full Text] [Related]
6. In vivo gp39-CD40 interactions occur in the non-follicular compartments of the spleen and are essential for thymus dependent antibody responses and germinal center formation.
van den Eertwegh AJ; Van Meurs M; Foy TM; Noelle RJ; Boersma WJ; Claassen E
Adv Exp Med Biol; 1994; 355():75-80. PubMed ID: 7535976
[No Abstract] [Full Text] [Related]
7. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
Lumsden JM; Williams JA; Hodes RJ
J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
[TBL] [Abstract][Full Text] [Related]
8. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
9. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
Bishop GA; Warren WD; Berton MT
Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
Wykes M; Poudrier J; Lindstedt R; Gray D
Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
[TBL] [Abstract][Full Text] [Related]
11. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.
Noelle RJ; Roy M; Shepherd DM; Stamenkovic I; Ledbetter JA; Aruffo A
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6550-4. PubMed ID: 1378631
[TBL] [Abstract][Full Text] [Related]
12. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
[TBL] [Abstract][Full Text] [Related]
13. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of the ligand for CD40 on T helper lymphocytes.
Castle BE; Kishimoto K; Stearns C; Brown ML; Kehry MR
J Immunol; 1993 Aug; 151(4):1777-88. PubMed ID: 8102152
[TBL] [Abstract][Full Text] [Related]
15. CD40 cross-linking inhibits specific antibody production by human B cells.
Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
[TBL] [Abstract][Full Text] [Related]
16. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
17. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
[TBL] [Abstract][Full Text] [Related]
18. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells.
Poudrier J; Owens T
Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo.
Smith KM; Pottage L; Thomas ER; Leishman AJ; Doig TN; Xu D; Liew FY; Garside P
J Immunol; 2000 Sep; 165(6):3136-44. PubMed ID: 10975827
[TBL] [Abstract][Full Text] [Related]
20. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
